Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia

• Status: Recruiting
• Trial end date: 2021-09-12
• Target enrollment: 0
• Participant gender: All

Summary

ivermectin is FDA approaved antiparasitic drug which is also claimed to be having potent in vitro antiviral effect,so we are tryying to study itsovid19 anosmia effect upon releiving post covid19 anosmia

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: South Valley University
• Treatments: Ivermectin

Criteria

Inclusion Criteria:

• post covid19 anosmia

• negative swab test for covid19

Exclusion Criteria:

• other types of anosmia ,

• no local or central other causes of anosmia

• still active covid 19 pateints ( positive swab test )